Sangamo Therapeutics Inc. buy skatcup
Start price
31.05.21
/
80%
€8.74
Target price
31.05.22
€15.00
Performance (%)
-60.61%
End price
01.06.22
€3.44
Summary
This prediction ended on 01.06.22 with a price of €3.44. The BUY prediction by skatcup for Sangamo Therapeutics Inc. performed very badly with a performance of -60.61%. skatcup has 80% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Sangamo Therapeutics Inc. | -5.095% | -5.095% | -67.855% |
| iShares Core DAX® | 2.112% | -0.367% | 13.466% |
| iShares Nasdaq 100 | -2.197% | -3.794% | 38.426% |
| iShares Nikkei 225® | -1.555% | -7.320% | 18.451% |
| iShares S&P 500 | -0.472% | -2.078% | 27.488% |
According to skatcup what are the pros and cons of Sangamo Therapeutics Inc. for the foreseeable future?
Pros
Fair valuation
Strong uniques
Leading role in innovation
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High Investments for future growth
Good culture
Top 10 in its market
Very small cyclical dependencies
Known brand
Very Future proof/growth oriented business model
Cons
Bad rating
Very low/no dividend yield expected
Risky balance sheet
Higher risks for its business
Comments by skatcup for this prediction
In the thread Sangamo Bioscienes diskutieren
Buy mit Kursziel 11,0
Kursziel geändert auf 12,0
Kursziel geändert auf 15,0
In the thread Trading Sangamo Bioscienes
Die von skatcup gewählte maximale Laufzeit wurde überschritten
Stopped prediction by skatcup for Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc.
Start price
Target price
Perf. (%)
€15.97
03.04.18
03.04.18
€26.16
22.10.18
22.10.18
-21.64%
22.10.18
22.10.18
Fair valuation
Strong uniques
Leading role in innovation
Bad rating
